Table 3

Incidence of abnormal findings at the initial and final study

Initial studyFinal study
n Abnormal % n Abnormal % p value
LVEF15311.007.199910.0010.100.605
RVEF15312.007.84998.008.080.861
LVPFR12618.0014.299528.0029.470.040
RVPFR1260.000.00954.004.210.077
LFRFP12638.0030.169529.0030.530.922
RVRFP12623.0018.259511.0011.580.325
LVSFP12615.0011.909522.0023.160.092
RVSFP1266.004.76953.003.160.818
LVACP12619.0015.089525.0026.320.129
RVACP1261.000.79954.004.210.233
LVRFF126104.0082.549575.0078.950.907
RVRFF1260.000.00950.000.00
LVSFF12647.0037.309529.0030.530.548
RVSFF1261.000.79954.004.210.233
LVACF126100.0079.379568.0071.580.649
RVACF1260.000.00950.000.00
  • See table 2 for units.

  • LVACF, left ventricular filling fraction of atrial contraction; LVACP, left atrial contraction period; LVEF, left ventricular ejection fraction; LVPFR, left ventricular peak filling rate; LVRFF, left ventricular rapid filling fraction; LVRFP, left ventricular rapid filling period; LVSFF, left ventricular slow filling fraction; LVSFP, left ventricular slow filling period, RVACF, right ventricular filling fraction of atrial contraction; RVACP, right atrial contraction period; RVEF, right ventricular ejection fraction; RVPFR, right ventricular peak filling rate; RVRFF, right ventricular rapid filling fraction; RVRFP, right ventricular rapid filling period; RVSFF, right ventricular slow filling fraction; RVSFP, right ventricular slow filling period; TGA, transposition of the great arteries.